Misty Robotics is acquired by leading social robotics company Furhat Robotics

Sweden-based Furhat Robotics acquires the business assets of Misty Robotics to accelerate development of next-generation social robots.

Boulder, CO – January 17th, 2022 – Misty Robotics today announces that the company is acquired by Furhat Robotics, the Swedish company behind the world’s most advanced social robot, ‘Furhat’. Furhat Robotics will continue to support the Misty Robotics brand and all of Misty’s customers, and empower future Misty robots through the strength of their technology. For Misty’s existing customers, nothing will change apart from the exciting addition of an extended community and more knowledge and research available.

Click here for more…..

TUI collaborates with Mobi to implement machine learning in cutting-edge digital operations platform

• Machine learning to enhance automated transfer platform

• Upgrade will increase efficiency, help reduce CO2 emissions

• TUI app to provide live vehicle tracking, transfer timing and notifications

• Platform launched this month in Mallorca, with further key destinations to be added throughout 2022

TUI Group, one of the world’s leading tourism groups, is implementing machine learning for its global shared-transfer operations platform in collaboration with Mobi Systems, a Boston based startup using advanced techniques to optimise scheduling. This continues TUI’s investment in digital platform capabilities and is part of a major upgrade to its operations system - increasing efficiency, enhancing service and supporting sustainable development.

In 2019, TUI sold over 31 million transfers, transporting customers between airports, hotels and points of interest in destinations around the world. Shared transfer scheduling is automated through TUI’s global transfer operations platform, but this will now be enhanced through additional machine learning capabilities.

Click here for more…..

Sensydia Receives FDA Breakthrough Device Designation for CPSTM Non-Invasive Cardiac Monitoring Device

Sensydia, an innovator in rapid, non-invasive measurement of critical cardiac function, today announced that its Cardiac Performance System (CPSTM) has been granted Breakthrough Device Designationby the United States Food and Drug Administration (FDA). As part of this Breakthrough Device Designation, the FDA will work closely with Sensydia to expedite the development of CPS and prioritize the review of subsequent regulatory submissions.   

CPS is a non-invasive cardiac monitoring device that reports critical heart performance measurements to physicians for comprehensive evaluation of patients with advanced and persistent heart failure, without requiring an in-hospital catheterization procedure or ultrasound assessment.

Click here for more…..